Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung Cancer

NCT07698054 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

130

Enrollment

OTHER_GOV

Sponsor class

Conditions

SCLC, Extensive Stage
Bayesian
Metronomic Chemotherapy

Interventions

DRUG: Toripalimab; Etoposide

Sponsor

Henan Cancer Hospital